{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:25:31Z","timestamp":1761017131144},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12933-015-0307-z","type":"journal-article","created":{"date-parts":[[2015,10,30]],"date-time":"2015-10-30T22:54:28Z","timestamp":1446245668000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Factors associated with no apparent coronary artery disease in patients with type 2 diabetes mellitus for more than 10\u00a0years of duration: a case control study"],"prefix":"10.1186","volume":"14","author":[{"given":"Mukund P.","family":"Srinivasan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Padmanabh K.","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narayan M.","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narasimha D.","family":"Pai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poornima A.","family":"Manjrekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chakrapani","family":"Mahabala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,31]]},"reference":[{"issue":"10","key":"307_CR1","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1161\/01.CIR.100.10.1134","volume":"100","author":"SM Grundy","year":"1999","unstructured":"Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;100(10):1134\u201346.","journal-title":"Circulation"},{"issue":"7","key":"307_CR2","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2337\/diacare.25.7.1135","volume":"25","author":"E Bonora","year":"2002","unstructured":"Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, et al. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care. 2002;25(7):1135\u201341.","journal-title":"Diabetes Care"},{"issue":"1","key":"307_CR3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12933-014-0142-7","volume":"13","author":"F Saraiva","year":"2014","unstructured":"Saraiva F, Sposito AC. Cardiovascular effects of glucagon-like peptide 1 (GLP-1) receptor agonists. Cardiovasc Diabetol. 2014;13(1):142.","journal-title":"Cardiovasc Diabetol"},{"key":"307_CR4","first-page":"1","volume":"6736","author":"T Tuomi","year":"2013","unstructured":"Tuomi T, Santoro N, Caprio S, Cai M, Weng J, Groop L. The many faces of diabetes: a disease with increasing heterogeneity. Lancet. 2013;6736:1\u201311.","journal-title":"Lancet"},{"key":"307_CR5","doi-asserted-by":"crossref","first-page":"611","DOI":"10.4103\/1947-2714.120799","volume":"5","author":"C Mahabala","year":"2013","unstructured":"Mahabala C, Srinivasan M, Manjrekar P, Unnikrishnan B, Ullal A, Kamath P, et al. Correlation of severity of coronary artery disease with insulin resistance. N Am J Med Sci. 2013;5:611.","journal-title":"N Am J Med Sci"},{"key":"307_CR6","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s001250051352","volume":"43","author":"A Natali","year":"2000","unstructured":"Natali A, Vichi S, Landi P, Severi S, Abbate AL, Ferrannini E. Rapid communication Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome. Diabetologia. 2000;43:632\u201341.","journal-title":"Diabetologia"},{"key":"307_CR7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1475-2840-12-140","volume":"12","author":"JY Kim","year":"2013","unstructured":"Kim JY, Choi EY, Mun HS, Min PK, Yoon YW, Lee BK, et al. Usefulness of metabolic syndrome score in the prediction of angiographic coronary artery disease severity according to the presence of diabetes mellitus: relation with inflammatory markers and adipokines. Cardiovasc Diabetol. 2013;12:140.","journal-title":"Cardiovasc Diabetol"},{"issue":"17","key":"307_CR8","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1001\/jama.2014.14681","volume":"312","author":"TM Maddox","year":"2014","unstructured":"Maddox TM, Stanislawski MA, Grunwald GK, Bradley SM, Ho PM, Tsai TT, et al. Nonobstructive coronary artery disease and risk of myocardial infarction. JAMA. 2014;312(17):1754\u201363.","journal-title":"JAMA"},{"issue":"1","key":"307_CR9","first-page":"62","volume":"33Suppl","author":"Diabetes DOF","year":"2010","unstructured":"Diabetes DOF. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33Suppl(1):62\u20139.","journal-title":"Diabetes Care"},{"issue":"7","key":"307_CR10","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.metabol.2013.01.006","volume":"62","author":"BJ Kwon","year":"2013","unstructured":"Kwon BJ, Kim DW, Her SH, Kim DB, Jang SW, Cho EJ, et al. Physical status: metabolically obese status with normal weight is associated with both the prevalence and severity of angiographic coronary artery disease. Metabolism. 2013;62(7):952\u201360.","journal-title":"Metabolism"},{"key":"307_CR11","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","volume":"27","author":"Wallace Tm","year":"2004","unstructured":"Tm Wallace, Levy JC, Matthews DR. Use and abuse of HOMA modelling. Diabetes Care. 2004;27:1487\u201395.","journal-title":"Diabetes Care"},{"key":"307_CR12","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2337\/diacare.24.2.362","volume":"24","author":"A Katsuki","year":"2001","unstructured":"Katsuki A, Sumida Y, Gabazza EC, Murashima S, Furuta M, Araki-Sasaki R, et al. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care. 2001;24:362\u20135.","journal-title":"Diabetes Care"},{"key":"307_CR13","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4103\/0019-5359.102124","volume":"64","author":"BK De","year":"2010","unstructured":"De BK, Mani S, Mandal SK, Mondal SS, Bhattacharya R, Pramanik AB, et al. Cryptogenic cirrhosis: metabolic liver disease due to insulin resistance. Indian J Med Sci. 2010;64:508\u201319.","journal-title":"Indian J Med Sci"},{"key":"307_CR14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1463-1326.2004.00438.x","volume":"7","author":"K Kwon","year":"2005","unstructured":"Kwon K, Choi D, Koo BK, Ryu SK. Decreased insulin sensitivity is associated with the extent of coronary artery disease in patients with angina pectoris. Diabetes obes meatb. 2005;7:579\u201385.","journal-title":"Diabetes obes meatb."},{"issue":"4","key":"307_CR15","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/CIRCINTERVENTIONS.108.847137","volume":"2","author":"D Capodanno","year":"2009","unstructured":"Capodanno D, Di Salvo ME, Cincotta G, Miano M, Tamburino C, Tamburino C. Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease. Circ Cardiovasc Interv. 2009;2(4):302\u20138.","journal-title":"Circ Cardiovasc Interv"},{"issue":"9","key":"307_CR16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/qjmed\/hcm066","volume":"100","author":"T Zornitzki","year":"2007","unstructured":"Zornitzki T, Ayzenberg O, Gandelman G, Vered S, Yaskil E, Faraggi D, et al. Diabetes, but not the metabolic syndrome, predicts the severity and extent of coronary artery disease in women. QJM. 2007;100(9):575\u201381.","journal-title":"QJM"},{"issue":"4","key":"307_CR17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1586\/erc.11.20","volume":"9","author":"A Aziz","year":"2011","unstructured":"Aziz A, Wheatcroft S. Insulin resistance in type 2 diabetes and obesity: implications for endothelial function. Expert Rev Cardiovasc Ther. 2011;9(4):403\u20137.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"307_CR18","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00018-007-6359-9","volume":"64","author":"JF Youngren","year":"2007","unstructured":"Youngren JF. Regulation of insulin receptor function. Cell Mol Life Sci. 2007;64:873\u201391.","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"307_CR19","doi-asserted-by":"crossref","first-page":"e108693","DOI":"10.1371\/journal.pone.0108693","volume":"9","author":"KJ Catalano","year":"2014","unstructured":"Catalano KJ, Maddux BA, Szary J, Youngren JF, Goldfine ID, Schaufele F. Insulin resistance induced by hyperinsulinemia coincides with a persistent alteration at the insulin receptor tyrosine kinase domain. PLoS One. 2014;9(9):e108693.","journal-title":"PLoS One"},{"issue":"12","key":"307_CR20","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","volume":"37","author":"Reaven","year":"1988","unstructured":"Reaven, Gerald M. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595\u2013607.","journal-title":"Diabetes"},{"key":"307_CR21","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2337\/dc06-0919","volume":"30","author":"E Bonora","year":"2007","unstructured":"Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, et al. Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the Bruneck study. Diabetes Care. 2007;30:318\u201324.","journal-title":"Diabetes Care"},{"key":"307_CR22","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.amjmed.2009.03.015","volume":"122","author":"DM Kendall","year":"2009","unstructured":"Kendall DM, Cuddihy RM, Bergenstal RM. Clinical application of incretin-based therapy: therapeutic potential, patient selection and clinical use. Am J Med. 2009;122:S37\u201350.","journal-title":"Am J Med"},{"key":"307_CR23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/(SICI)1096-9136(199804)15:4<297::AID-DIA572>3.3.CO;2-N","volume":"15","author":"DR Matthews","year":"1998","unstructured":"Matthews, Cull CA, Stratton IM, Holman RR, Turner RC. UKPDS 26: sulphonylurea failure in non-insulin-dependent diabetic patients over 6\u00a0years. UK prospective diabetes study (UKPDS) group. Diabet Med. 1998;15:297\u2013303.","journal-title":"Diabet Med"},{"key":"307_CR24","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2337\/diab.44.11.1249","volume":"44","author":"Diabetes UKP, Group S","year":"1995","unstructured":"Diabetes UKP, Group S. Perspectives in Diabetes UK. Prospective diabetes study 16 overview of 6 Years \u2018Therapy of type II diabetes: a progressive disease. Diabetes. 1995;44:1249\u201358.","journal-title":"Diabetes"},{"issue":"14s1","key":"307_CR25","doi-asserted-by":"crossref","first-page":"E1439","DOI":"10.1016\/S0735-1097(11)61439-3","volume":"57","author":"A Vonbank","year":"2011","unstructured":"Vonbank A, Saely CH, Rein P, Beer S, Boehnel C, et al. Insulin resistance is associated with metabolic syndrome but not with angiographically determined coronary artery disease in female patients. J Am Coll Cardiol. 2011;57(14s1):E1439.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"307_CR26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2337\/diacare.29.01.06.dc05-1422","volume":"29","author":"E Cosson","year":"2006","unstructured":"Cosson E, Pham I, Valensi P, Pari\u00e8s J, Attali JR, Nitenberg A. Impaired coronary endothelium-dependent vasodilation is associated with microalbuminuria in patients with type 2 diabetes and angiographically normal coronary arteries. Diabetes Care. 2006;29(1):107\u201312.","journal-title":"Diabetes Care"},{"issue":"4","key":"307_CR27","doi-asserted-by":"crossref","first-page":"982","DOI":"10.2337\/dc10-1718","volume":"34","author":"CC Hsu","year":"2011","unstructured":"Hsu CC, Chang HY, Huang MC, Yang YC, Tai TY, et al. Association between insulin resistance and development of microalbuminuria in type 2 diabetes: a prospective cohort study. Diabetes Care. 2011;34(4):982\u20137.","journal-title":"Diabetes Care"},{"issue":"5","key":"307_CR28","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.2337\/db05-1484","volume":"55","author":"AI Parvanova","year":"2006","unstructured":"Parvanova AI, Trevisan R, Iliev IP, Dimitrov BD, Vedovato M, Tiengo A, et al. Insulin resistance and microalbuminuria: a cross-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion. Diabetes. 2006;55(5):1456\u201362.","journal-title":"Diabetes"},{"issue":"5","key":"307_CR29","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/00024677-200605050-00002","volume":"5","author":"AR Vasudevan","year":"2006","unstructured":"Vasudevan AR, Burns A, Fonseca VA. The effectiveness of intensive glycemic for the prevention of vascular complications in diabetes mellitus. Treat Endocrinol. 2006;5(5):273\u201386.","journal-title":"Treat Endocrinol"},{"key":"307_CR30","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","volume":"358","author":"HC Gerstein","year":"2008","unstructured":"Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC, Bigger JT, Buse JB, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545\u201359.","journal-title":"N Engl J Med"},{"key":"307_CR31","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.9734\/BJMMR\/2014\/11169","volume":"4","author":"MP Srinivasan","year":"2014","unstructured":"Srinivasan MP, Kamath PK, Pai ND, Manjrekar PA, Mahabala C. Factors correlating with severity of coronary artery disease in Type 2 diabetic patients on treatment for more than 5\u00a0years. BJMMR. 2014;4:4364\u201372.","journal-title":"BJMMR"},{"key":"307_CR32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12933-015-0238-8","volume":"14","author":"SH Kim","year":"2015","unstructured":"Kim SH, Moon JY, Lim YM, Kim KH, Yang WI, Sung JH, et al. Association of insulin resistance and coronary artery remodeling: an intravascular ultrasound study. Cardiovasc Diabetol. 2015;14:74.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-015-0307-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T18:37:55Z","timestamp":1498243075000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cardiab.com\/content\/14\/1\/146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,31]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["307"],"URL":"https:\/\/doi.org\/10.1186\/s12933-015-0307-z","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,31]]},"article-number":"146"}}